BiosciGen’s Post

Did you know that medicines are the largest source of expenditure for most medical institutions, second only to human resources? 💊 💉 📈 Across the #Commonwealth, pharmacists have both a unique expertise to offer and a critical role to play in developing more resilient, sustainable and equitable medicine distribution systems - especially at a time when medicines are becoming more costly across the world. That's why today our CEO Victoria Rutter and Trustee Zaheer-Ud-Din Babar led a webinar on pharmaceutical pricing for the Commonwealth Heads of Procurement Network (HOPN), with roundtable discussion moderated by Commonwealth Secretariat Health Advisor Janneth Mghamba. Professor Babar is a world-leading expert in pharmaceutical policy and pricing with more than 300 papers to his name. Our HOPN webinars bring together leaders in medicine procurement and storage from across the Commonwealth to discuss shared challenges and share best practice for increasing equitable access to essential medicines, providing vital context and learning to help shape decisions that impact the lives of patients around the Commonwealth. #pharmacy #CPApharm #health #healthcare #medicine #pharma

Today, we celebrate the incredible role pharmacists play in advancing healthcare and improving lives around the world. Whether you're in a hospital, community pharmacy, research lab, or the pharmaceutical industry, your dedication and expertise contribute to the well-being of millions every day. This year's theme, #Pharmacy: Strengthening Health Systems", highlights the essential part pharmacists play in enhancing patient care, ensuring safe medication use, and leading innovations in health technologies. To all the pharmacists out there: your passion, knowledge, and commitment are making a global impact. Let’s continue to drive positive change in healthcare and strive for a healthier future together! #WorldPharmacistsDay #Virtuosopharma #HealthcareHeroes #PharmaceuticalInnovation #StrongerHealthSystems

We are glad to finally launch our Healthcare Biz LinkedIn Page where we will bringing you developments around the #healthcare space, including #medical research #breakthroughs as well as other #research findings and breaking news with a link to healthcare. Happy reading! #healthcarenews #health #pharmaceuticals #medicare #medicaldevices #healthcare #hospitalisation #medicalbenefits

🎥 Curious about the real impact of drug diversion in healthcare? Learn expert insights with Adam Beeler, PharmD, MS, Director of Pharmacy Services at Protenus in this eye-opening snippet about how much drug diversion is occurring from a recent interview. Gain essential knowledge and understand the challenges facing diversion programs today. Ready for more? Watch the full interview here: https://hubs.ly/Q02Vnm_g0 #DrugDiversion #HealthcareChallenges #Hospitals #HealthcareAI #Pharmacy #HealthcareInnovation

GRG Health conducted a comprehensive study on the GLP-1 market in India, interviewing 20 healthcare professionals, including Diabetologists, Endocrinologists, and General Practitioners. The findings highlighted significant benefits of GLP-1 therapies in diabetes management but identified challenges such as high costs, limited availability, and lack of awareness. Key strategies for overcoming these barriers include cost reduction through generics, education, and training for healthcare providers, patient awareness campaigns, and improved distribution logistics. The study underscores the need for targeted interventions to enhance the adoption of GLP-1 therapies, aiming to improve patient outcomes and expand market reach. #GLP1Market #HealthcareInsights #DiabetesManagement #PharmaResearch #MarketChallenges #HealthcareSolutions #PatientOutcomes #MedicalResearch #Pharmaceuticals #IndiaHealthcare Tanvi Kapoor Bahl

Pharma's $637 billion problem. The pharmaceutical industry is losing $637 billion annually due to medication non-adherence. That's the equivalent of throwing away the GDP of Switzerland... every single year. The reasons for non-adherence are complex, but one often-overlooked factor is packaging design. A confusing pill bottle, a hard-to-open blister pack, or an uninspiring aesthetic can all contribute to a patient's reluctance to take their medication as prescribed. Here's what the research tells us: - Elderly patients are particularly vulnerable to packaging-related non-adherence, with difficulties in opening and understanding instructions cited as major barriers. (Journal of the American Geriatrics Society) - The World Health Organization recognizes that simplifying packaging is a key strategy to improve adherence. - A report from Healthcare Packaging indicates that intuitive, patient-centric packaging can improve adherence rates by up to 20%. We understand that every medication and every patient population is unique. That's why we offer customized packaging solutions that consider the specific needs of each product and its target audience. Don't let poor packaging design stand in the way of patient well-being and your bottom line. Let us help you turn your packaging into a powerful tool for adherence and success. #patientadherence #pharma #packaging

On #WorldHealthDay, Raptim Research reaffirms its dedication to the fundamental principle: 'My Health, My Right'. Let's empower individuals worldwide to take charge of their health journey. 🌍💪 #HealthForAll #MyHealthMyRight"

Spain’s Ministry of Health has released the new Health Technology Assessment (HTA) Royal Decree for public consultation, introducing updated guidelines for evaluating drugs, medical devices, and other health technologies. Here are three key points: 1. Two-Tier Evaluation System: The decree establishes a clear distinction between clinical and non-clinical evaluations, including economic factors. 2. Increased Transparency: Developers must now provide detailed cost data, ensuring that evaluations remain independent of funding decisions. 3. Stakeholder Involvement: The new framework mandates input from patients and healthcare professionals before technologies are integrated into the National Health System (SNS). As these changes reshape the landscape, it's crucial for pharmaceutical and medical technology companies to adapt swiftly. Lyfegen can help you stay ahead with our cutting-edge solutions: - Navigate New Regulatory Requirements: Access our extensive Agreements Library, featuring over 5,000+ public drug pricing agreements and 20 pricing models, to ensure compliance with the latest HTA standards. - Optimize Decision-Making: Utilize our Drug Contracting Simulator to create data-driven business cases and run real-time simulations that align with Spain's new HTA guidelines. - Streamline and Automate Contracting: Our Rebate Analytics solutions automate rebate and refund calculations, ensuring accuracy, transparency, and a significant reduction in administrative burdens. Book a demo with us today to explore how Lyfegen’s tools and expertise can support your business under Spain’s new HTA framework. Book your demo here: https://hubs.la/Q02L3LFB0 #HTASpain #SpainHealth #HealthTechnology #PharmaSpain #MedTechSpain #HealthcareRegulations #ValueBasedCare #HealthcareInnovation

If your meals might make your medication less effective, or even harmful, you'd want to know. And you'd want to adjust. Drug-food interactions are one of five factors our APPRAISE™ platform tests for. Our insights provide: — A complete understanding of how your body may interact with medication — Precise, actionable recommendations (from our Precision Clinical Pharmacists). With the APPRAISE, healthcare providers can shape optimized medication regimens. Patients can see better outcomes. Providers and payers can see lower costs. It's a broad step into the future of medication safety. Learn more: https://lnkd.in/gS6u2VwJ #Pharmacogenomics #Pharmacokinetics #HealthTech #MedTech #Biotechnology

This has to be the future for pharmacy. Community pharmacies have such a unique position and standing within their neighbours and are the most accessible healthcare professional. The same interpersonal and analytical skills applied in hospital, general practice and other settings mean the whole profession has a lot to offer here. I see supporting populations to manage and maintain a healthy weight and other CVD risk factors as being core to this. It should be the substantive part of any future local or national strategy. I understand the need and rationale for a degree of minor ailment, emergency condition management type service, but if that is the long term plan, it risks presenting community pharmacy with the same accessibility problems GPs have now and doesn't play to our strengths. Prevention and pharmaceutical public health is much more sustainable as a service model and is what the country needs to make systemic prevention a reality.